PRP Joint Therapy Solutions in Ann Arbor, MI

How Ann Arbor is not Florida First Coast

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. 6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick prp joint therapy against that mix.

Where Ann Arbor programs actually stall

• Adult arthritis here is 16.7% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Michigan.
• Joint-preservation biologics compete with cortisone and viscosupplementation pathways that already have familiar CPT habits. The operational gap in Michigan is staff training and consent language, not another brand name on a centrifuge.
• Michigan is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

Uninsured mix and Medicare CTPs in the same building

America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Ann Arbor we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure.

Staff, tickets, photos — in that order